Matches in Wikidata for { <http://www.wikidata.org/entity/Q88373624> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q88373624 description "artículu científicu espublizáu en mayu de 2018" @default.
- Q88373624 description "bài báo khoa học" @default.
- Q88373624 description "scientific article published on 08 May 2018" @default.
- Q88373624 description "wetenschappelijk artikel" @default.
- Q88373624 description "наукова стаття, опублікована в травні 2018" @default.
- Q88373624 name "Baseline neutrophil-to-lymphocyte ratio in patients with advanced melanoma treated with immune checkpoint inhibitors" @default.
- Q88373624 name "Baseline neutrophil-to-lymphocyte ratio in patients with advanced melanoma treated with immune checkpoint inhibitors" @default.
- Q88373624 type Item @default.
- Q88373624 label "Baseline neutrophil-to-lymphocyte ratio in patients with advanced melanoma treated with immune checkpoint inhibitors" @default.
- Q88373624 label "Baseline neutrophil-to-lymphocyte ratio in patients with advanced melanoma treated with immune checkpoint inhibitors" @default.
- Q88373624 prefLabel "Baseline neutrophil-to-lymphocyte ratio in patients with advanced melanoma treated with immune checkpoint inhibitors" @default.
- Q88373624 prefLabel "Baseline neutrophil-to-lymphocyte ratio in patients with advanced melanoma treated with immune checkpoint inhibitors" @default.
- Q88373624 P1433 Q88373624-972B8BB6-15D0-417D-9CB1-1B21A1EFC4B3 @default.
- Q88373624 P1476 Q88373624-E33A946D-2CC2-4296-BC69-3A8DC819204D @default.
- Q88373624 P2093 Q88373624-1438B991-E2A5-4342-AE93-92D6ECEBA35F @default.
- Q88373624 P2093 Q88373624-4FA3DDE4-3741-47C6-B175-092F64B6D093 @default.
- Q88373624 P2093 Q88373624-A25E1305-E65F-4368-ACA4-E89ACF359FE4 @default.
- Q88373624 P2093 Q88373624-F8D386BE-CEDF-47A2-9518-102CF730DE24 @default.
- Q88373624 P304 Q88373624-B3956879-4108-4850-BC08-02A0020BA121 @default.
- Q88373624 P31 Q88373624-D935FD55-250E-456E-8389-D21952F00F27 @default.
- Q88373624 P356 Q88373624-880AA5E3-77F7-4DF5-9889-49B00299FE54 @default.
- Q88373624 P433 Q88373624-3718FCD1-8EBF-4AEF-924B-8DE6F64D6409 @default.
- Q88373624 P478 Q88373624-8AA09C4D-F736-4E03-A0BA-768F3F859073 @default.
- Q88373624 P50 Q88373624-52CA16B0-D7D0-4335-8C7D-932955443839 @default.
- Q88373624 P50 Q88373624-82B94C78-BDB6-474B-BC02-D5CB2F23DF4E @default.
- Q88373624 P577 Q88373624-205B739D-780A-49F8-BBBF-D605BE36BD45 @default.
- Q88373624 P698 Q88373624-4EF6D42A-E8F8-4F51-8048-A4468249D791 @default.
- Q88373624 P356 BJD.16675 @default.
- Q88373624 P698 29660775 @default.
- Q88373624 P1433 Q4970191 @default.
- Q88373624 P1476 "Baseline neutrophil-to-lymphocyte ratio in patients with advanced melanoma treated with immune checkpoint inhibitors" @default.
- Q88373624 P2093 "A Finon" @default.
- Q88373624 P2093 "H Maillard" @default.
- Q88373624 P2093 "J Zaragoza" @default.
- Q88373624 P2093 "M Garnier" @default.
- Q88373624 P304 "224" @default.
- Q88373624 P31 Q13442814 @default.
- Q88373624 P356 "10.1111/BJD.16675" @default.
- Q88373624 P433 "1" @default.
- Q88373624 P478 "179" @default.
- Q88373624 P50 Q42661870 @default.
- Q88373624 P50 Q57046117 @default.
- Q88373624 P577 "2018-05-08T00:00:00Z" @default.
- Q88373624 P698 "29660775" @default.